UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000057132
Receipt number R000065305
Scientific Title A placebo-controlled double-blind study of improvement of skin elasticity and moisture by ingestion of test food in healthy participant
Date of disclosure of the study information 2026/04/30
Last modified on 2025/02/26 00:36:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect evaluation test on improvement of skin elasticity and moisture by ingestion of test food

Acronym

Effect evaluation test on improvement of skin elasticity and moisture by ingestion of test food

Scientific Title

A placebo-controlled double-blind study of improvement of skin elasticity and moisture by ingestion of test food in healthy participant

Scientific Title:Acronym

Improvement of skin elasticity and moisture test

Region

Japan


Condition

Condition

Healthy people

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the effect of collagen peptide intake on improving skin elasticity and moisture compared to placebo and before intake by evaluating skin condition before and after intake of the test food (1 week) in a placebo-controlled double-blind study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin elasticity, skin moisture content, skin evaporation rate, collagen content, dermis thickness

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake placebo food for 4 weeks.

Interventions/Control_2

Intake 20g / day of test food A for 4 weeks.

Interventions/Control_3

Intake 10g / day of test food A for 4 weeks.

Interventions/Control_4

Intake 20g / day of test food B for 4 weeks.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Age: 30 years old or older, 60 years old or younger
2) Gender: Male and female
3) Healthy individuals with skin problems
4) Those who can provide written consent to participate in the study
5) Those who expected to be able to complete the study

Key exclusion criteria

1) Pregnant or breastfeeding women
2) Those prone to anemia
3) Those currently undergoing ongoing medical treatment or taking medication
4) Those with a history of cardiovascular disease or renal dysfunction
5) Those with nervous system disease or metabolic disorders
6) Those deemed inappropriate by the principal investigator
7) Those taking medication other than those listed above that may affect the results of the study
8) Those already participating in other clinical trials
9) Those who have taken collagen continuously within the past month prior to starting this study

Target sample size

88


Research contact person

Name of lead principal investigator

1st name Megumi
Middle name
Last name Murata

Organization

Nitta Gelatin Inc.

Division name

Research Department Center

Zip code

581-0024

Address

2-22, Futamata, Yao city, Osaka

TEL

072-948-8256

Email

me-murata@nitta-gelatin.co.jp


Public contact

Name of contact person

1st name Megumi
Middle name
Last name Murata

Organization

Nitta Gelatin Inc.

Division name

Research Department Center

Zip code

581-0024

Address

2-22, Futamata, Yao city, Osaka

TEL

072-948-8256

Homepage URL


Email

me-murata@nitta-gelatin.co.jp


Sponsor or person

Institute

Nitta Gelatin Inc.

Institute

Department

Personal name



Funding Source

Organization

Nitta Gelatin Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Osaka Nishiumeda Clinic Research Ethics Review Committee

Address

3F Maruito Nishiumeda Build. 3-3-45 Umeda, Kita-ku, Osaka

Tel

06-4797-5660

Email

nouchi@taifukukai.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 02 Month 06 Day

Date of IRB

2025 Year 02 Month 07 Day

Anticipated trial start date

2025 Year 02 Month 10 Day

Last follow-up date

2025 Year 04 Month 02 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 02 Month 26 Day

Last modified on

2025 Year 02 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000065305